CHMP issues positive opinion recommending DARZALEX® (daratumumab) for relapsed or refractory multiple myeloma
admin 27th February 2017 Uncategorised 0Genmab
More: CHMP issues positive opinion recommending DARZALEX® (daratumumab) for relapsed or refractory multiple myeloma
Source: MDlinx